Healthcare

Health Care

Our foray into international healthcare reflects our assessment of the long-term potential of this industry. One of the fastest growing business sectors across the world, healthcare is modernising rapidly based on improvements in diagnostic services, medical treatments and gained rapid importance post Covid-19.

Through our international subsidiary, we have acquired a majority stake in TIASH Pte. Ltd., which itself controls two specialised healthcare services firms - The Iron Suites, TIS-Health and Compai Pharma. The Iron Suites has set-up an Integrative Medical Centre with a focus on treatment and management of iron deficiency. Over the years the belief that nutritional and holistic health is the foundation of wellness, longevity and quality of life has strengthened which led to the concept of The Integrative Medical Centre.

We believe a significant market exists for intravenous iron - research suggests that as many as 1 in 3 women of childbearing age may suffer from iron deficiency. Compai Pharma is focussed on in-licensing pharmaceutical products, and is headquartered in Singapore, with presence in Malaysia

Our foray into international healthcare reflects our assessment of the long-term potential of this industry. One of the fastest growing business sectors across the world, healthcare is modernising rapidly based on improvements in diagnostic services and medical treatments.

The first Iron Clinic was set up in Singapore where research has found that approximately 1 in 3 women of childbearing age may be unknowingly suffering from iron deficiency. Being a leading centre for the administration of intravenous iron, the clinic focusses on the management of iron deficiency. With the conversion of Iron Clinic to The Integrative Medical Centre, we are offering additional services of Nutritional Health, Women’s health, Aesthetics, Naturopathy, Dietetics, Osteopathy, Physiotherapy etc. Geographical expansion of the clinics is being considered presently.
Headquartered in Singapore and with a presence in Malaysia, the company is specialized in in-licensing and distribution of pharmaceutical products. Has the exclusive distribution right for “Monofer” an intravenous iron drug owned by the Danish company Pharmacosmos A/S for Malaysia and Singapore. Sales of Monofer commenced in Malaysia in Nov 2018 and in Singapore in Feb 2020. The Company employs a specialized team of experienced sales and medical professionals.